BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12576809)

  • 21. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
    Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
    Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
    Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
    Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage pT3a of renal clear cell carcinoma: do tumors with sinus fat involvement behave the same as those with perinephric fat involvement?
    Chaves Portela S; Santos-Arrontes D; Fernández-Aceñero MJ; García González J; Paniagua P
    Rom J Morphol Embryol; 2011; 52(2):569-74. PubMed ID: 21655644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
    Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
    Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
    Klatte T; Chung J; Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy.
    Thompson RH; Cheville JC; Lohse CM; Webster WS; Zincke H; Kwon ED; Frank I; Blute ML; Leibovich BC
    Cancer; 2005 Jul; 104(1):53-60. PubMed ID: 15895375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
    Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
    J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-institutional validation of a symptom based classification for renal cell carcinoma.
    Patard JJ; Leray E; Cindolo L; Ficarra V; Rodriguez A; De La Taille A; Tostain J; Artibani W; Abbou CC; Guillé F; Chopin DK; Lobel B
    J Urol; 2004 Sep; 172(3):858-62. PubMed ID: 15310983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of the 1997 TNM classification of renal cell carcinoma.
    Javidan J; Stricker HJ; Tamboli P; Amin MB; Peabody JO; Deshpande A; Menon M; Amin MB
    J Urol; 1999 Oct; 162(4):1277-81. PubMed ID: 10492179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of tumor size in renal cell cancer with perinephric fat infiltration: is TNM staging system adequate for predicting prognosis?
    Süer E; Baltaci S; Burgu B; Aydoğdu Ö; Göğüş Ç
    Urol J; 2013; 10(1):774-9. PubMed ID: 23504681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
    Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
    J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
    J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal metastases from renal cell carcinoma: role of ipsilateral adrenalectomy and definition of stage.
    Sandock DS; Seftel AD; Resnick MI
    Urology; 1997 Jan; 49(1):28-31. PubMed ID: 9000180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of the adrenal gland during partial nephrectomy.
    Lane BR; Tiong HY; Campbell SC; Fergany AF; Weight CJ; Larson BT; Novick AC; Flechner SM
    J Urol; 2009 Jun; 181(6):2430-6; discussion 2436-7. PubMed ID: 19371896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.